Romito, I., Porru, M., Braghini, M. R., Pompili, L., Panera, N., Crudele, A., . . . Alisi, A. (2021). Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects. BMC.
Style de citation Chicago (17e éd.)Romito, Ilaria, et al. Focal Adhesion Kinase Inhibitor TAE226 Combined with Sorafenib Slows Down Hepatocellular Carcinoma by Multiple Epigenetic Effects. BMC, 2021.
Style de citation MLA (8e éd.)Romito, Ilaria, et al. Focal Adhesion Kinase Inhibitor TAE226 Combined with Sorafenib Slows Down Hepatocellular Carcinoma by Multiple Epigenetic Effects. BMC, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.